BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gáll Z, Farkas S, Albert Á, Ferencz E, Vancea S, Urkon M, Kolcsár M. Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression. Biomolecules 2020;10:E801. [PMID: 32455953 DOI: 10.3390/biom10050801] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Chahuan S, Grover S, Singh S. Amelioration of modified chronic unpredictable stress using Celastrus paniculatus seed oil alone and in combination with fluoxetine. Drug Chem Toxicol 2022;:1-16. [PMID: 35943180 DOI: 10.1080/01480545.2022.2105862] [Reference Citation Analysis]
2 Santiago-castañeda C, Huerta de la Cruz S, Martínez-aguirre C, Orozco-suárez SA, Rocha L. Cannabidiol Reduces Short- and Long-Term High Glutamate Release after Severe Traumatic Brain Injury and Improves Functional Recovery. Pharmaceutics 2022;14:1609. [DOI: 10.3390/pharmaceutics14081609] [Reference Citation Analysis]
3 Zhao D, Zhang J, Zhu Y, He C, Fei W, Yue N, Wang C, Wang L. Study of Antidepressant-Like Effects of Albiflorin and Paeoniflorin Through Metabolomics From the Perspective of Cancer-Related Depression. Front Neurol 2022;13:828612. [DOI: 10.3389/fneur.2022.828612] [Reference Citation Analysis]
4 Bright U, Akirav I. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence. IJMS 2022;23:5526. [DOI: 10.3390/ijms23105526] [Reference Citation Analysis]
5 Rachayon M, Jirakran K, Sodsai P, Klinchanhom S, Sughondhabirom A, Plaimas K, Suratanee A, Maes M. In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls. Pharmaceuticals 2022;15:405. [DOI: 10.3390/ph15040405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Joshi A, Akhtar A, Saroj P, Kuhad A, Sah SP. Antidepressant-like effect of sodium orthovanadate in a mouse model of chronic unpredictable mild stress. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Albrakati A, Alsharif KF, Al Omairi NE, Alsanie WF, Almalki ASA, Abd Elmageed ZY, Elshopakey GE, Lokman MS, Bauomy AA, Abdel Moneim AE, Kassab RB. Neuroprotective Efficiency of Prodigiosins Conjugated with Selenium Nanoparticles in Rats Exposed to Chronic Unpredictable Mild Stress is Mediated Through Antioxidative, Anti-Inflammatory, Anti-Apoptotic, and Neuromodulatory Activities. Int J Nanomedicine 2021;16:8447-64. [PMID: 35002238 DOI: 10.2147/IJN.S323436] [Reference Citation Analysis]
8 Martín-Sánchez A, González-Pardo H, Alegre-Zurano L, Castro-Zavala A, López-Taboada I, Valverde O, Conejo NM. Early-life stress induces emotional and molecular alterations in female mice that are partially reversed by cannabidiol. Prog Neuropsychopharmacol Biol Psychiatry 2021;115:110508. [PMID: 34973413 DOI: 10.1016/j.pnpbp.2021.110508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Silote GP, Gatto MC, Eskelund A, Guimarães FS, Wegener G, Joca SRL. Strain-, Sex-, and Time-Dependent Antidepressant-like Effects of Cannabidiol. Pharmaceuticals (Basel) 2021;14:1269. [PMID: 34959670 DOI: 10.3390/ph14121269] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Reyes-Cuapio E, Coronado-Álvarez A, Quiroga C, Alcaraz-Silva J, Ruíz-Ruíz JC, Imperatori C, Murillo-Rodríguez E. Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats. Eur J Pharmacol 2021;910:174463. [PMID: 34478689 DOI: 10.1016/j.ejphar.2021.174463] [Reference Citation Analysis]
11 Stark T, Di Martino S, Drago F, Wotjak CT, Micale V. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment. Pharmacol Res 2021;174:105938. [PMID: 34655773 DOI: 10.1016/j.phrs.2021.105938] [Reference Citation Analysis]
12 Martin EL, Strickland JC, Schlienz NJ, Munson J, Jackson H, Bonn-Miller MO, Vandrey R. Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Front Psychiatry 2021;12:729800. [PMID: 34566726 DOI: 10.3389/fpsyt.2021.729800] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Jiang H, Li H, Cao Y, Zhang R, Zhou L, Zhou Y, Zeng X, Wu J, Wu D, Wu D, Guo X, Li X, Wu H, Li P. Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats. Brain Res 2021;1768:147586. [PMID: 34289379 DOI: 10.1016/j.brainres.2021.147586] [Reference Citation Analysis]
14 Li S, Xu W, Gong L, Zhang J, Zhang Y, Chen J, Yu J, Xu J. Subchronic nonylphenol exposure induced anxiety-like behavior and decreased expressions of regulators of synaptic plasticity in rats. Chemosphere 2021;282:130994. [PMID: 34102488 DOI: 10.1016/j.chemosphere.2021.130994] [Reference Citation Analysis]
15 Langlois C, Potvin S, Khullar A, Tourjman SV. Down and High: Reflections Regarding Depression and Cannabis. Front Psychiatry 2021;12:625158. [PMID: 34054594 DOI: 10.3389/fpsyt.2021.625158] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Jeon SC, Kim HJ, Ko EA, Jung SC. Prenatal Exposure to High Cortisol Induces ADHD-like Behaviors with Delay in Spatial Cognitive Functions during the Post-weaning Period in Rats. Exp Neurobiol 2021;30:87-100. [PMID: 33632985 DOI: 10.5607/en20057] [Reference Citation Analysis]
17 Malinowska B, Baranowska-Kuczko M, Kicman A, Schlicker E. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci 2021;22:1986. [PMID: 33671463 DOI: 10.3390/ijms22041986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pesarico AP, Chagas PM, Nacher J. Editorial: Animal Models of Stress - Current Knowledge and Potential Directions. Front Behav Neurosci 2021;15:655214. [PMID: 33664658 DOI: 10.3389/fnbeh.2021.655214] [Reference Citation Analysis]
19 Romano B, Lucariello G, Capasso R. Topical Collection "Pharmacology of Medicinal Plants". Biomolecules 2021;11:101. [PMID: 33466709 DOI: 10.3390/biom11010101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Wanner NM, Colwell M, Drown C, Faulk C. Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice. Clin Epigenetics 2021;13:4. [PMID: 33407853 DOI: 10.1186/s13148-020-00993-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
21 García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders. Biomolecules 2020;10:E1575. [PMID: 33228239 DOI: 10.3390/biom10111575] [Cited by in Crossref: 18] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
22 Costa R, Carvalho MSM, Brandão JDP, Moreira RP, Cunha TS, Casarini DE, Marcondes FK. Modulatory action of environmental enrichment on hormonal and behavioral responses induced by chronic stress in rats: Hypothalamic renin-angiotensin system components. Behav Brain Res 2021;397:112928. [PMID: 32987059 DOI: 10.1016/j.bbr.2020.112928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]